Professor David Thorburn is co-Group Leader of Brain & Mitochondrial Research at the Murdoch Children's Research Institute and an Honorary Professorial Fellow in the Department of Paediatrics at the University of Melbourne. He is also a National Health & Medical Research Council Principal Research Fellow and leads the Victorian Clinical Genetics Services Mitochondrial Diagnostic Laboratory.
His group is primarily involved in researching the genetic basis of mitochondrial energy generation disorders. They were among the first to use Next Generation Sequencing technologies to identify mutations in known and novel disease genes. This subsequently expanded into multi-omic approaches incorporating transcriptomics and proteomics to identify candidate genes and provide functional validation of genomic variants. His team has identified pathogenic mutations in >600 patients in >100 genes, including 13 mitochondrial DNA genes and 30 novel nuclear disease genes.
As co-lead of the Australian Genomics Mitochondrial Flagship (2017-20) and Lead of the Medical Research Future Fund-supported MitoMDT project (2021-25), he has developed national networks seeking to incorporate genomic and multi-omic testing into Australian healthcare. He is a member of the executive of RDNow, whose vision is to enable all children seen on the Royal Children’s Hospital campus with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention. As a Director of the Mito Foundation, he was the academic/research Lead for the Foundation’s campaign to legalise mitochondrial donation, culminating in Maeve’s law being legislated in 2022.
Professor David Thorburn is co-Group Leader of Brain & Mitochondrial Research at the Murdoch Children's Research Institute and an Honorary Professorial Fellow in the Department of Paediatrics at the University of Melbourne. He is also a National...
Professor David Thorburn is co-Group Leader of Brain & Mitochondrial Research at the Murdoch Children's Research Institute and an Honorary Professorial Fellow in the Department of Paediatrics at the University of Melbourne. He is also a National Health & Medical Research Council Principal Research Fellow and leads the Victorian Clinical Genetics Services Mitochondrial Diagnostic Laboratory.
His group is primarily involved in researching the genetic basis of mitochondrial energy generation disorders. They were among the first to use Next Generation Sequencing technologies to identify mutations in known and novel disease genes. This subsequently expanded into multi-omic approaches incorporating transcriptomics and proteomics to identify candidate genes and provide functional validation of genomic variants. His team has identified pathogenic mutations in >600 patients in >100 genes, including 13 mitochondrial DNA genes and 30 novel nuclear disease genes.
As co-lead of the Australian Genomics Mitochondrial Flagship (2017-20) and Lead of the Medical Research Future Fund-supported MitoMDT project (2021-25), he has developed national networks seeking to incorporate genomic and multi-omic testing into Australian healthcare. He is a member of the executive of RDNow, whose vision is to enable all children seen on the Royal Children’s Hospital campus with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention. As a Director of the Mito Foundation, he was the academic/research Lead for the Foundation’s campaign to legalise mitochondrial donation, culminating in Maeve’s law being legislated in 2022.
Top Publications
Kang, Y, Stroud, DA, Baker, MJ, De Souza, DP, Frazier, AE, Liem, M, Tull, D, Mathivanan, S, McConville, MJ, Thorburn, DR, et al.
Sengers Syndrome-Associated Mitochondrial Acylglycerol Kinase Is a Subunit of the Human TIM22 Protein Import Complex..
Mol Cell
67(3)
:
457 -470.e5
2017
view publication
Desai, R, Frazier, AE, Durigon, R, Patel, H, Jones, AW, Dalla Rosa, I, Lake, NJ, Compton, AG, Mountford, HS, Tucker, EJ, et al.
ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism..
Brain
140(6)
:
1595 -1610
2017
view publication
Ng, GZ, Ke, B-X, Laskowski, A, Thorburn, DR, Sutton, P.
No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis..
Helicobacter
22(3)
:
2017
view publication
Karaa, A, Rahman, S, Lombès, A, Yu-Wai-Man, P, Sheikh, MK, Alai-Hansen, S, Cohen, BH, Dimmock, D, Emrick, L, Falk, MJ, et al.
Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project..
J Inherit Metab Dis
40(3)
:
403 -414
2017
view publication
Riley, LG, Cowley, MJ, Gayevskiy, V, Roscioli, T, Thorburn, DR, Prelog, K, Bahlo, M, Sue, CM, Balasubramaniam, S, Christodoulou, J.
A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders..
J Inherit Metab Dis
40(2)
:
261 -269
2017
view publication